The trademark application Galecto was filed by Galecto Biotech AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on November 16, 2020, and it was registered by office on February 23, 2021 without any oppositions.
The application was filed in Danish (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on June 27, 2022.
Goods And Services
The mark was filed in class 5 with Pharmaceutical, medical and veterinary medicinal products for treatment of cancer, fibrotic diseases, autoimmune diseases, neurodegenerative diseases, viral infections, acute inflammatory conditions, transplant rejection.
The mark was filed in class 42 with Providing medical research information and related materials, namely, biological, chemical, pharmaceutical and clinical data in the field of diagnostic, prophylactic and therapeutic properties of pharmaceuticals for treatment of cancer, fibrotic diseases, autoimmune diseases, neurodegenerative diseases, viral infections, acute inflammatory conditions, transplant rejection, and indications hereof.